← Leaderboards
Jeffrey Peters
Cardialen, Inc.
$3,176,687
Attributed
$3,176,687
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–23$2M$1.5M$1M$500K$0
'21
'22
'23
Funding mix
By agency
NIH$3,176,687 · 2
By mechanism
R44$3,176,687 · 2
Top collaborators
No co-investigators on record.
Most similar at Cardialen, Inc.
Same institution · by research overlap
- David W Bourn$2,818,462
- Daniel H Cooper$664,268
- Wenwen Li$216,027
- Qun Sha$125,371
- Michael Brent Shelton$450,576
Others in their field
Other Emerging Leaders on “Epidemic”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
- Kathleen Maletic Neuzil · Emory University$27,014,427
- Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences$19,743,439
- Ashlee Fitch · Steelworker Charitable/Educational Org$18,884,919
Research focus
EpidemicFallsEffectivenessElectric CountershockEvaluationExercise CapacityConsultDementiaCostDefibrillatorsDevicesDoctor Of PhilosophyCanis FamiliarisArrhythmiaAtrial FibrillationCardiac Electrophysiologic TechniquesAffectCommunitiesCicatrixAblationClinical PracticeClinical TrialsAmericanFda Approved
Grant awards (4)
Implantable Unpinning Termination Therapy for Cardiac Arrhythmias$998,941
R44 · FY2023 · HL · contact PI
Implantable Unpinning Termination Therapy for Cardiac Arrhythmias$999,810
R44 · FY2022 · HL · contact PI
Novel Therapy System for Atrial Fibrillation$650,906
R44 · FY2021 · HL · contact PI
Novel Therapy System for Atrial Fibrillation$527,030
R44 · FY2021 · HL · contact PI